In summary, we have demonstrated how a new UA and PTX combination treatment suppresses esophageal cancer cell growth and tumorigenesis by inhibiting FOXM1 expression via the Akt signaling pathway (Figure 10). Here, FOXM1 is linked to esophageal cancer.